The content on this site is intended for healthcare professionals only
Prof Mohty talks to ecancertv at ICMM 2016 about maintenance therapy in young myeloma patients after undergoing autologous stem cell transplant.
He explains how it is beneficial but that information is still lacking regarding which patients will respond most favourably.
He also tells us about the treatment of old but fit patients.
Understanding more about combinations and sequences will be key, he says.
ecancer's filming at ICMM 2016 has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content
New classification for identifying HR myeloma based on cytogenetic abnormalities
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Revolutionising myeloma treatment through immune profiling
Advancements in paediatric Acute lymphoblastic leukemia management
Choosing 1st line TKI Wisely in patients with CML
ESMO 2024: Optimising the personalisation of prostate cancer treatment
Encouraging results using mismatched unrelated donors in stem cell transplantation
Multiple myeloma in a resource constrained setting
Relapsed refractory multiple myeloma
